THBS1, a potent inhibitor of neovascularization with known relevance to AMD pathology43–46, showed both increased expression and enhanced extracellular deposition on stiffer substrates, suggesting strengthened anti-angiogenic barriers under these conditions. Here, THBS1 is linked to age-related macular degeneration.